Catalyst Event

Medtronic PLC (MDT) · Other

From Akros U.S. Tech 100 Protective Allocation Monthly Index (A100PAM)

4/25/2026, 12:00:00 AM

OtherSentiment: Positive

Announced positive clinical study milestones for its Affera cardiac arrhythmia technologies, including FDA Breakthrough Device designation for the Sphere-9 catheter on 2026-04-25.

Korean Translation

2026-04-25에 Sphere-9 카테터에 대한 FDA 혁신 의료기기 지정을 포함하여, 아페라(Affera) 심장 부정맥 기술에 대한 긍정적인 임상 연구 이정표를 발표함.

Related Recent Events

View Full Timeline